1. Netherlands Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Corbion N.V.

Corbion N.V.

CSNVY
Corbion N.V.US flagOther OTC
22.25
USD
- -
- -
1.28BMarket Cap
Corbion N.V.
CSNVY
(Other OTC)

Recent

price

22.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
44.3
10.23
10.48
10.55
12.46
15.2
15.6
15.35
15.28
16.61
16.75
18.18
24.71
21.4
22.05
21.86
Revenue per Share
1.47
-2.56
-0.96
-0.01
-0.33
1.29
1.74
1.46
0.93
0.44
1.24
1.33
1.53
1.23
3.29
1.29
Basic EPS, GAAP
1.7
0.76
2.01
-0.8
-0.02
0.83
1.15
2.03
1.7
1.95
1.85
0.38
0.66
2.8
3.15
2.77
Free Cash Flow per Basic Share
0.54
0.33
0.3
0.99
0.09
0.97
0.9
1.04
0.56
0.56
0.56
0.56
0.56
0.56
0.72
0.64
Dividend per Share
15.04
11.34
9.32
5.92
6.26
5.98
6.1
6.36
6.71
6.49
7.1
7.56
8.62
9.4
11.82
12.44
Book Value per Share
-0.44
0.1
9.74
5.78
6.24
5.78
6.17
6.18
6.49
6.06
5.95
6.73
7.83
8.12
11.53
11.27
Tangible Book Value per Share
68
70
72
70
62
60
58
58
59
59
59
59
59
59
58
58
Basic Weighted Avg Shares
2,990
714
754
744
770
918
911
892
897
976
986
1,071
1,458
1,264
1,288
1,267
Sales/Revenue/Turnover
5.29
6.96
4.99
5.04
1.68
11.83
13.93
13.72
9.8
6.28
9.12
4.39
7.11
6.53
5.94
9.19
Operating Margin (%)
107
36
43
41
44
46
50
45
42
62
60
64
76
85
87
86
Depreciation Expense
99
-174
-65
2
-18
80
104
85
54
26
73
78
90
73
192
75
Net Income, GAAP
23.91
- -
- -
72.92
1,063.16
21.53
12.13
13.41
22.21
42.28
16.65
9.48
22.68
5.07
26.56
21.18
Effective Tax Rate (%)
3.32
-24.4
-8.66
0.3
-2.38
8.73
11.37
9.49
6.05
2.64
7.41
7.31
6.17
5.77
14.92
5.9
Profit Margin (%)
324
350
1,021
186
132
197
200
133
90
25
151
184
62
-9
75
273
Working Capital
- -
727
604
94
36
154
133
117
134
169
284
419
437
417
308
348
LT Debt
1,117
919
794
505
509
488
498
489
520
529
516
554
626
636
772
743
Total Equity
9.73
- -
- -
1.01
-20.34
12.86
16.31
15.84
9.44
4.26
8.58
4.41
6.51
5.53
4.13
7.39
Return on Invested Capital (%)
9.41
- -
- -
0.65
-13.23
15.98
20.26
17.21
10.71
4.94
11.38
10.66
9.31
7.75
16.41
7.38
Return on Capital (%)
9.99
-19.77
-9.44
-0.11
-5.15
20.86
28.3
23.31
14.22
6.65
18.27
18.14
18.88
13.7
30.85
10.59
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.54%
7.91%
-3.87%
Free Cash Flow
42.13%
63.49%
-12.6%
Net Income, GAAP
21.15%
21.12%
-61.08%
Sales/Revenue/Turnover
3.93%
6.34%
-1.61%
Total Cash Common Dividend
- -
- -
-11.22%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,288
2025
- -
- -
- -
- -
1,267
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.29
2025
- -
- -
- -
- -
1.29
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.72
2025
- -
- -
- -
- -
0.64
2026
- -
- -
- -
- -
- -
Similar Companies
Zenova Group Plc (ZED.L)
Manali Petrochemicals Limited (MANALIPETC.BO)
Hindprakash Industries Limited (HPIL.BO)
Tenma Corporation (7958.T)
Guangdong Hongda Holdings Group Co., Ltd. (002683.SZ)
Polyplex (Thailand) Public Company Limited (PTL-R.BK)
Business
Corbion N.V. (CSNVY) manufactures and markets sustainable biobased ingredients, specializing in lactic acid and its derivatives, food preservation solutions, functional blends, algae ingredients, and biochemicals derived from fermentation processes; its core offerings span emulsifiers, enzymes, antioxidants, mold inhibitors, omega-3 algae products, and lactides for applications in food preservation, bakery, meat, dairy, animal nutrition, home and personal care, pharmaceuticals, medical devices, bioplastics, electronics, and packaging. The company operates globally with production facilities in Europe, North America, Asia, and Latin America, targeting food manufacturers, biochemical processors, and industrial customers seeking natural and sustainable solutions. Founded in 1919 and headquartered in Amsterdam, Netherlands, Corbion lists on Euronext Amsterdam and reported €1,332.0 million in annual sales for 2024 with 2,399 full-time employees. Recent developments include a strategic partnership with BRAIN Biotech AG announced in August 2025 to advance nature-based ingredient technologies; a collaboration with Kuehnle AgroSystems for algae-based innovations; the launch of Verdad Essence WH100 natural mold inhibitor and innovative egg replacers in April 2025 to address bakery supply challenges; expansion of the partnership with IMCD for specialty chemicals distribution; acquisition of a bread improver business from Novotech to strengthen its Indian market presence; multiple share buyback programs totaling up to €30 million in 2024-2025; a USD 100 million debt issuance via US Private Placement in 2025; facility upgrades in Mexico and new product introductions for refrigerated foods and AI-enhanced Listeria control models; and executive changes such as the appointment of Masha Vis-Mertens as Chief Human Resources Officer in 2024.

Company News

APIChat

  • seekingalpha.com

    Corbion N.V. (CSNVY) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    Corbion N.V. (CSNVY) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Corbion N.V. (CSNVY) Analyst/Investor Day Transcript

  • globenewswire.com

    Corbion reports the progress of its share buyback program 6 October – 10 October 2025

  • globenewswire.com

    Corbion reports the progress of its share buyback program 29 September – 3 October 2025

  • globenewswire.com

    Corbion joins the Ferment4Health Project to unlock the gut health potential of fermented foods

  • globenewswire.com

    Corbion General Shareholders Meeting approves Board (re)appointments and dividend

  • seekingalpha.com

    Corbion N.V. (CSNVF) Q4 2024 Earnings Call Transcript